OWP Pharmaceuticals, Inc.
Manufacturer / marketing-authorisation holder
OWP Pharmaceuticals, Inc. — 15 products across 1 markets, 3 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
OWP Pharmaceuticals, Inc. — 15 productos en 1 mercados, 3 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
OWP Pharmaceuticals, Inc. —— 共 15 个产品，覆盖 1 个市场、3 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
15 products · 1 markets · 3 brand names
15 productos · 1 mercados · 3 marcas
15 个产品 · 1 个市场 · 3 个品牌名
Products by country
US
Source: api.fda.gov
| Brand | Active ingredient(s) | Form |
|---|---|---|
| LAMOTRIGINE Kit | Ingredient not recorded (name-level) | kit |
| LAMOTRIGINE Kit | Ingredient not recorded (name-level) | kit |
| Roweepra | 左乙拉西坦 | tablet |
| SUBVENITE | 拉莫三嗪 | tablet |
| SUBVENITE | 拉莫三嗪 | tablet |
| SUBVENITE | Ingredient not recorded (name-level) | kit |
| SUBVENITE | Ingredient not recorded (name-level) | kit |
| SUBVENITE | 拉莫三嗪 | tablet |
| SUBVENITE | 拉莫三嗪 | tablet |
| SUBVENITE | Ingredient not recorded (name-level) | kit |
| SUBVENITE | 拉莫三嗪 | liquid |
| — | 拉莫三嗪 | tablet |
| — | 左乙拉西坦 | tablet |
| — | 左乙拉西坦 | tablet |
| — | 左乙拉西坦 | tablet |